GLOW
Coming soonGLOW is one lyophilized vial supplying GHK-Cu, BPC-157 and TB-500 together. Each component is also listed on its own page with its chemistry and cited studies.
Supplied as a co-lyophilized vial with a colour-coded cap (Recovery & Repair).
Research literature, not dosing or treatment instructions.
- GHK-Cu: GHK binds copper(II) with an affinity similar to the copper transport site on albumin, and the complex is called GHK-Cu. (PMID 18644225)
- BPC-157: In cultured rat tendon cells BPC 157 was examined for effects on tendon outgrowth, cell survival and cell migration. (PMID 21030672)
- TB-500: Thymosin beta 4 is described as the main G-actin sequestering peptide in mammalian tissue and as a mediator of cell migration, proliferation and differentiation. (PMID 14500546)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about GLOW
Is GLOW an approved medicine?
GLOW combines research compounds we also list on their own. It is not a medicinal product, and it is supplied for in-vitro laboratory research only, not for human or veterinary use. Regulator records are listed per component on the pages of GHK-Cu, BPC-157 and TB-500.
What is the difference between GLOW and KLOW?
KLOW supplies the three GLOW components (GHK-Cu, BPC-157 and TB-500) plus the tripeptide KPV. GLOW has no fourth component.
Is there published research on GLOW as a combination?
No formulation-level literature is listed. Each component's page lists its own studies. The page of each component in the research library lists its own studies.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
Often studied with
For research use only. Not for human or veterinary use.
What is GLOW?
GLOW is a catalog item that supplies GHK-Cu, BPC-157 and TB-500 together in one vial. Each component keeps its own chemistry, cited studies and regulator records, listed below. We supply GLOW as a lyophilized vial for in-vitro laboratory research only.
What does a GLOW vial contain?
GLOW supplies GHK-Cu, BPC-157 and TB-500 together in one vial. The single compounds are listed separately; the amount of each in the vial is shown on the product options.
What does published research on GLOW cover?
GLOW combines compounds we also list on their own, so no study covers this exact vial. Each component has its own studies, checked in PubMed on 5 October 2026. One cited study per component follows.
- GHK-Cu: GHK binds copper(II) with an affinity similar to the copper transport site on albumin, and the complex is called GHK-Cu. (Pickart, J Biomater Sci Polym Ed, 2008; PMID 18644225)
- BPC-157: In cultured rat tendon cells BPC 157 was examined for effects on tendon outgrowth, cell survival and cell migration. (Chang et al., J Appl Physiol (1985), 2011; PMID 21030672)
- TB-500: Thymosin beta 4 is described as the main G-actin sequestering peptide in mammalian tissue and as a mediator of cell migration, proliferation and differentiation. (Philp et al., FASEB J, 2003; PMID 14500546)
Mechanism, every cited study and the regulator records are on the GLOW page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is GLOW supplied and stored?
GLOW is supplied as a co-lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of GLOW?
GLOW combines research compounds we also list on their own. It is not a medicinal product. Regulator records are listed per component.
GHK-Cu: Drugs@FDA lists no application naming prezatide or GHK as an active ingredient (checked 5 October 2026).
BPC-157: Drugs@FDA lists no application naming BPC-157 or BPC 157 as an active ingredient (checked 5 October 2026).
TB-500: Drugs@FDA lists no application naming thymosin beta 4 or timbetasin or thymosin beta-4 as an active ingredient (checked 5 October 2026).
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
Components in the catalog: